Oncology conditions, page 1 of 7
20 conditions on this page, alphabetically from Acute megakaryocytic leukemia to Brain cancer. Each entry below describes the condition in full.
On this page
Acute megakaryocytic leukemia
An acute myeloid leukemia that derives from blood-forming tissue in which megakaryocytes proliferate in the bone marrow and circulate in the blood in large numbers. Patients with acute megakaryocytic leukemia are cared for through our Oncology service line.
Also known as
- Megakaryocytic myelosis
- Thrombocytic leukaemia
Classification
Ontology identifier: DOID:8761 (Human Disease Ontology).
Classification path: disease of cellular proliferation › cancer › organ system cancer › hematologic cancer › leukemia › myeloid leukemia › acute myeloid leukemia.
Specialty: Oncology
Broader conditions
Medical codes
- ICD-10-CM: C94.2
- ICD-9-CM: 207.2
- MeSH: D007947
- SNOMED CT: 52220008
Care at Weyland-Yutani Health System
Oncology specialists lead care for acute megakaryocytic leukemia. Plans are tailored to each patient and reviewed regularly.
Treatment options
Diagnostic tests
When to seek care
Seek a medical evaluation if you are concerned about acute megakaryocytic leukemia. Bring a list of current medications and any previous test results.
Reference links
Acute myeloid leukemia
A myeloid leukemia that is characterized by the rapid growth of abnormal white blood cells that accumulate in the bone marrow and interfere with the production of normal blood cells. This page summarizes how acute myeloid leukemia is classified and the care available at Weyland-Yutani Health System.
Also known as
- acute myeloblastic leukaemia
- acute myeloblastic leukemia
- acute myelogenous leukaemia
- acute myelogenous leukemia
- acute myeloid leukaemia
- AML - acute Myeloid Leukemia
- Leukemia, Myelocytic, acute
Classification
Ontology identifier: DOID:9119 (Human Disease Ontology).
Classification path: disease of cellular proliferation › cancer › organ system cancer › hematologic cancer › leukemia › myeloid leukemia.
Specialty: Oncology
Broader conditions
More specific conditions
Medical codes
- ICD-10-CM: C92.0
- ICD-9-CM: 205.0
- MeSH: D015470
- OMIM: 601626
- SNOMED CT: 17788007
Care at Weyland-Yutani Health System
At Weyland-Yutani Health System, acute myeloid leukemia is managed by Oncology with support from imaging, laboratory and rehabilitation services where needed.
Treatment options
Diagnostic tests
When to seek care
Questions about acute myeloid leukemia? Call your nearest Weyland-Yutani location and ask for Oncology.
Reference links
Acute myeloid leukemia without maturation
acute myeloid leukemia without maturation: An acute myeloid leukemia that is characterized by blasts without evidence of significant maturation in the neutrophilic lineage.
Classification
Ontology identifier: DOID:0081086 (Human Disease Ontology).
Classification path: disease of cellular proliferation › cancer › organ system cancer › hematologic cancer › leukemia › myeloid leukemia › acute myeloid leukemia.
Specialty: Oncology
Broader conditions
Medical codes
- ICD-10-CM: C92.0
- MeSH: D015470
- SNOMED CT: 103690005
Care at Weyland-Yutani Health System
Care for acute myeloid leukemia without maturation is coordinated through Oncology. Your clinician will recommend tests and treatments based on your history and symptoms.
Treatment options
Diagnostic tests
Related articles
When to seek care
Seek a medical evaluation if you are concerned about acute myeloid leukemia without maturation. Bring a list of current medications and any previous test results.
Reference links
Adenocarcinoma
A carcinoma that has_material_basis_in abnormally proliferating cells, derives_from epithelial cells, which originate in glandular tissue. This page summarizes how adenocarcinoma is classified and the care available at Weyland-Yutani Health System.
Classification
Ontology identifier: DOID:299 (Human Disease Ontology).
Classification path: disease of cellular proliferation › cancer › cell type cancer › carcinoma.
Specialty: Oncology
Broader conditions
More specific conditions
Medical codes
- MeSH: D000230
- SNOMED CT: 35917007
Care at Weyland-Yutani Health System
Care for adenocarcinoma is coordinated through Oncology. Your clinician will recommend tests and treatments based on your history and symptoms.
Treatment options
Diagnostic tests
When to seek care
Seek a medical evaluation if you are concerned about adenocarcinoma. Bring a list of current medications and any previous test results.
Reference links
Adenocarcinoma in situ
An in situ carcinoma that derives_from epithelial cells of glandular origin. Patients with adenocarcinoma in situ are cared for through our Oncology service line.
Classification
Ontology identifier: DOID:4943 (Human Disease Ontology).
Classification path: disease of cellular proliferation › pre-malignant neoplasm › in situ carcinoma.
Specialty: Oncology
Broader conditions
Medical codes
- MeSH: D065311
- SNOMED CT: 51642000
Care at Weyland-Yutani Health System
Treatment of adenocarcinoma in situ begins with an evaluation in Oncology. Follow-up visits track how you are responding to care.
Treatment options
Diagnostic tests
When to seek care
Seek a medical evaluation if you are concerned about adenocarcinoma in situ. Bring a list of current medications and any previous test results.
Reference links
Adenoma
A cell type benign neoplasm that is composed_of epithelial tissue in which tumor cells form glands or glandlike structures. Patients with adenoma are cared for through our Oncology service line.
Also known as
- acinar cell adenoma
- acinic cell adenoma
- adenomas
Classification
Ontology identifier: DOID:657 (Human Disease Ontology).
Classification path: disease of cellular proliferation › benign neoplasm › cell type benign neoplasm.
Specialty: Oncology
More specific conditions
Medical codes
- MeSH: D000236
- SNOMED CT: 443416007
- SNOMED CT: 79041005
Care at Weyland-Yutani Health System
Oncology specialists lead care for adenoma. Plans are tailored to each patient and reviewed regularly.
Treatment options
Diagnostic tests
Related articles
When to seek care
Questions about adenoma? Call your nearest Weyland-Yutani location and ask for Oncology.
Reference links
Adult teratoma
A benign teratoma that is present in an adult. This page summarizes how adult teratoma is classified and the care available at Weyland-Yutani Health System.
Classification
Ontology identifier: DOID:5565 (Human Disease Ontology).
Classification path: disease of cellular proliferation › benign neoplasm › cell type benign neoplasm › germ cell benign neoplasm › benign teratoma.
Specialty: Oncology
Medical codes
Care at Weyland-Yutani Health System
Oncology specialists lead care for adult teratoma. Plans are tailored to each patient and reviewed regularly.
Treatment options
Diagnostic tests
Related articles
When to seek care
Seek a medical evaluation if you are concerned about adult teratoma. Bring a list of current medications and any previous test results.
Reference links
Aggressive NK-cell leukemia
Overview. A leukemia that is characterized by the systemic proliferation of NK cells closely associated with Epstein-Barr virus and that is located_in the peripheral blood, bone marrow, liver, and spleen. Weyland-Yutani Health System offers diagnosis and ongoing care for aggressive NK-cell leukemia.
Also known as
- aggressive NK-cell leukaemia
- large granular Lymphocyte Leukemia, NK-cell type
- natural killer cell leukaemia
- natural killer cell leukemia
Classification
Ontology identifier: DOID:1035 (Human Disease Ontology).
Classification path: disease of cellular proliferation › cancer › cell type cancer.
Specialty: Oncology
Broader conditions
Medical codes
- ICD-10-CM: C94.8
- SNOMED CT: 128833001
Care at Weyland-Yutani Health System
Treatment of aggressive NK-cell leukemia begins with an evaluation in Oncology. Follow-up visits track how you are responding to care.
Treatment options
Diagnostic tests
When to seek care
Questions about aggressive NK-cell leukemia? Call your nearest Weyland-Yutani location and ask for Oncology.
Reference links
Angiosarcoma
Overview. A vascular cancer that derives_from the cells that line the walls of blood vessels or lymphatic vessels. Weyland-Yutani Health System offers diagnosis and ongoing care for angiosarcoma.
Also known as
Classification
Ontology identifier: DOID:0001816 (Human Disease Ontology).
Classification path: disease of cellular proliferation › cancer › organ system cancer › cardiovascular cancer › vascular cancer.
Specialty: Oncology
Broader conditions
More specific conditions
Medical codes
- MeSH: D006394
- SNOMED CT: 39000009
Care at Weyland-Yutani Health System
At Weyland-Yutani Health System, angiosarcoma is managed by Oncology with support from imaging, laboratory and rehabilitation services where needed.
Treatment options
Diagnostic tests
When to seek care
Seek a medical evaluation if you are concerned about angiosarcoma. Bring a list of current medications and any previous test results.
Reference links
Appendix adenocarcinoma
An appendix carcinoma that derives_from epithelial cells of glandular origin. Our Oncology team evaluates and manages appendix adenocarcinoma.
Also known as
- Appendiceal adenocarcinoma
Classification
Ontology identifier: DOID:3608 (Human Disease Ontology).
Classification path: disease of cellular proliferation › cancer › cell type cancer › carcinoma › adenocarcinoma.
Specialty: Oncology
Broader conditions
Medical codes
Care at Weyland-Yutani Health System
Oncology specialists lead care for appendix adenocarcinoma. Plans are tailored to each patient and reviewed regularly.
Treatment options
Diagnostic tests
Related articles
When to seek care
If you or a family member may have appendix adenocarcinoma, contact your primary care provider or schedule a visit with Oncology.
Reference links
Appendix carcinoma
appendix carcinoma: An appendix cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells.
Also known as
- Ca appendix
- carcinoma of appendix
Classification
Ontology identifier: DOID:4902 (Human Disease Ontology).
Classification path: disease of cellular proliferation › cancer › organ system cancer › gastrointestinal system cancer › intestinal cancer › appendix cancer.
Specialty: Oncology
Broader conditions
More specific conditions
Medical codes
Care at Weyland-Yutani Health System
Care for appendix carcinoma is coordinated through Oncology. Your clinician will recommend tests and treatments based on your history and symptoms.
Treatment options
Diagnostic tests
Related articles
When to seek care
Questions about appendix carcinoma? Call your nearest Weyland-Yutani location and ask for Oncology.
Reference links
B-cell lymphoma
Overview. A non-Hodgkin lymphoma that has_material_basis_in B cells. Weyland-Yutani Health System offers diagnosis and ongoing care for B-cell lymphoma.
Also known as
- B-cell lymphocytic neoplasm
Classification
Ontology identifier: DOID:707 (Human Disease Ontology).
Classification path: disease of cellular proliferation › cancer › organ system cancer › immune system cancer › lymphatic system cancer › lymphoma › non-Hodgkin lymphoma.
Specialty: Oncology
Broader conditions
More specific conditions
Medical codes
- MeSH: D016393
- SNOMED CT: 109979007
Care at Weyland-Yutani Health System
Oncology specialists lead care for B-cell lymphoma. Plans are tailored to each patient and reviewed regularly.
Treatment options
Diagnostic tests
When to seek care
Seek a medical evaluation if you are concerned about B-cell lymphoma. Bring a list of current medications and any previous test results.
Reference links
Basal cell carcinoma
basal cell carcinoma: A skin carcinoma affecting basal cells.
Also known as
- Basal cell cancer
- Basal cell carcinoma of skin
- Basal cell neoplasm
- Basal cell tumor
- Epithelioma basal cell
- malignant Basal cell neoplasm
- malignant basal cell tumor
- Rodent ulcer
Classification
Ontology identifier: DOID:2513 (Human Disease Ontology).
Classification path: disease of cellular proliferation › cancer › cell type cancer › carcinoma › skin carcinoma.
Specialty: Oncology
Broader conditions
Medical codes
- MeSH: D018295
- SNOMED CT: 127570002
- SNOMED CT: 154507009
- SNOMED CT: 252995000
Care at Weyland-Yutani Health System
Treatment of basal cell carcinoma begins with an evaluation in Oncology. Follow-up visits track how you are responding to care.
Treatment options
Diagnostic tests
When to seek care
Seek a medical evaluation if you are concerned about basal cell carcinoma. Bring a list of current medications and any previous test results.
Reference links
Benign ileal neoplasm
A small intestine benign neoplasm that affects the wall of the ileum. Patients with benign ileal neoplasm are cared for through our Oncology service line.
Also known as
Classification
Ontology identifier: DOID:10156 (Human Disease Ontology).
Classification path: disease of cellular proliferation › benign neoplasm › organ system benign neoplasm › gastrointestinal system benign neoplasm › intestinal benign neoplasm › small intestine benign neoplasm.
Specialty: Oncology
Broader conditions
Medical codes
- MeSH: D007078
- SNOMED CT: 254576003
Care at Weyland-Yutani Health System
Treatment of benign ileal neoplasm begins with an evaluation in Oncology. Follow-up visits track how you are responding to care.
Treatment options
Diagnostic tests
Related articles
When to seek care
Questions about benign ileal neoplasm? Call your nearest Weyland-Yutani location and ask for Oncology.
Reference links
Bile duct adenoma
A biliary tract benign neoplasm that results_in a small firm white nodule with multiple bile ducts that are located_in a fibrous stroma. Patients with bile duct adenoma are cared for through our Oncology service line.
Also known as
Classification
Ontology identifier: DOID:5381 (Human Disease Ontology).
Classification path: disease of cellular proliferation › benign neoplasm › organ system benign neoplasm › gastrointestinal system benign neoplasm › hepatobiliary benign neoplasm › biliary tract benign neoplasm.
Specialty: Oncology
Broader conditions
Medical codes
- MeSH: D002759
- SNOMED CT: 39471001
Care at Weyland-Yutani Health System
Treatment of bile duct adenoma begins with an evaluation in Oncology. Follow-up visits track how you are responding to care.
Treatment options
Diagnostic tests
When to seek care
Questions about bile duct adenoma? Call your nearest Weyland-Yutani location and ask for Oncology.
Reference links
Bile duct cystadenoma
Overview. A biliary tract benign neoplasm that is located_in the bile duct and derives_from epithelial cells. Weyland-Yutani Health System offers diagnosis and ongoing care for bile duct cystadenoma.
Also known as
- Cystadenoma of the bile duct
Classification
Ontology identifier: DOID:5384 (Human Disease Ontology).
Classification path: disease of cellular proliferation › benign neoplasm › organ system benign neoplasm › gastrointestinal system benign neoplasm › hepatobiliary benign neoplasm › biliary tract benign neoplasm.
Specialty: Oncology
Broader conditions
Medical codes
Care at Weyland-Yutani Health System
Care for bile duct cystadenoma is coordinated through Oncology. Your clinician will recommend tests and treatments based on your history and symptoms.
Treatment options
Diagnostic tests
When to seek care
Questions about bile duct cystadenoma? Call your nearest Weyland-Yutani location and ask for Oncology.
Reference links
Biliary papillomatosis
biliary papillomatosis: A biliary tract benign neoplasm characterized by multiple papillary tumors in the intrahepatic and/or extrahepatic biliary tree.
Also known as
Classification
Ontology identifier: DOID:5468 (Human Disease Ontology).
Classification path: disease of cellular proliferation › benign neoplasm › organ system benign neoplasm › gastrointestinal system benign neoplasm › hepatobiliary benign neoplasm › biliary tract benign neoplasm.
Specialty: Oncology
Broader conditions
Medical codes
Care at Weyland-Yutani Health System
Treatment of biliary papillomatosis begins with an evaluation in Oncology. Follow-up visits track how you are responding to care.
Treatment options
Diagnostic tests
When to seek care
Seek a medical evaluation if you are concerned about biliary papillomatosis. Bring a list of current medications and any previous test results.
Reference links
Biliary tract benign neoplasm
biliary tract benign neoplasm: A hepatobiliary benign neoplasm located_in the biliary tract.
Also known as
- extrahepatic bile duct neoplasm
- neoplasm of extrahepatic bile ducts
- tumor of the extrahepatic bile duct
Classification
Ontology identifier: DOID:0050625 (Human Disease Ontology).
Classification path: disease of cellular proliferation › benign neoplasm › organ system benign neoplasm › gastrointestinal system benign neoplasm › hepatobiliary benign neoplasm.
Specialty: Oncology
Broader conditions
More specific conditions
Medical codes
Care at Weyland-Yutani Health System
At Weyland-Yutani Health System, biliary tract benign neoplasm is managed by Oncology with support from imaging, laboratory and rehabilitation services where needed.
Treatment options
Diagnostic tests
When to seek care
If you or a family member may have biliary tract benign neoplasm, contact your primary care provider or schedule a visit with Oncology.
Reference links
Bizarre leiomyoma
Overview. A leiomyoma that is characterized by large, atypical nuclei in otherwise normal appearing leiomyoma and rare or absent mitotic figures. Weyland-Yutani Health System offers diagnosis and ongoing care for bizarre leiomyoma.
Also known as
- Atypical leiomyoma
- Pleomorphic leiomyoma
- Symplastic leiomyoma
Classification
Ontology identifier: DOID:5127 (Human Disease Ontology).
Classification path: disease of cellular proliferation › benign neoplasm › cell type benign neoplasm › leiomyoma.
Specialty: Oncology
Broader conditions
Medical codes
Care at Weyland-Yutani Health System
At Weyland-Yutani Health System, bizarre leiomyoma is managed by Oncology with support from imaging, laboratory and rehabilitation services where needed.
Treatment options
Diagnostic tests
Related articles
When to seek care
Questions about bizarre leiomyoma? Call your nearest Weyland-Yutani location and ask for Oncology.
Reference links
Brain cancer
brain cancer: A central nervous system cancer that is characterized by the growth of abnormal cells in the tissues of the brain.
Also known as
- adult brain tumor
- adult malignant brain neoplasm
- brain neoplasm
- brain neoplasm, adult
- BT - Brain tumour
- malignant brain tumour
- malignant primary brain neoplasm
- malignant primary brain tumor
- malignant tumor of adult brain
- malignant tumor of Brain
- neoplasm of brain
- primary brain neoplasm
- primary brain tumor
- primary malignant neoplasm of brain
- tumor of the Brain
Classification
Ontology identifier: DOID:1319 (Human Disease Ontology).
Classification path: disease of cellular proliferation › cancer › organ system cancer › nervous system cancer › central nervous system cancer.
Specialty: Oncology
Broader conditions
More specific conditions
Medical codes
- ICD-10-CM: C71
- ICD-9-CM: 191
- ICD-9-CM: 239.6
- MeSH: D001932
- SNOMED CT: 126952004
- SNOMED CT: 428061005
- SNOMED CT: 93727008
Care at Weyland-Yutani Health System
Care for brain cancer is coordinated through Oncology. Your clinician will recommend tests and treatments based on your history and symptoms.
Treatment options
Diagnostic tests
Related articles
When to seek care
If you or a family member may have brain cancer, contact your primary care provider or schedule a visit with Oncology.
Reference links